The Efficacy of Diode Laser and Subgingival Air Polishing With Erythritol in Treatment of Periodontitis
The Efficacy of Diode Laser and Subgingival Air Polishing With Erythritol in Treatment of Periodontitis ( Clinical and Microbiological Study)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Periodontitis, a chronic condition, leads to inflammation of the periodontium, resulting in the degradation of the periodontal ligament and adjacent alveolar bone, potentially leading to tooth loss The oral cavity, hosting nearly 700 distinct bacteria, is the primary origin of periodontitis, where bacterial pathogens trigger an inflammatory response, causing connective tissue deterioration. Gram-negative bacteria, including Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, and Tannerella forsythia, contribute to periodontitis.
Dental plaque illustrates bacterial growth in the form of a biofilm Porphyromonas gingivalis, a Gram-negative anaerobic bacterium, is found in 85.75% of subgingival plaques associated with chronic periodontitis. The presence of Aggregatibacter actinomycetemcomitans at the individual level is notably associated with disease risk due to its genetic variation and virulence factors.
Exclusive reliance on mechanical therapy (SRP) may fall short in eliminating pathogenic bacterial species due to their presence within periodontal tissues or in regions inaccessible by periodontal instruments during close debridement. These challenges pose constraints on the enduring stability of outcomes in nonsurgical techniques, forming the rationale for supplementary therapies involving antibiotics, antiseptics, nonchemical modalities, laser, and photodynamic therapy.
Laser therapy, particularly the diode laser at 940 nm, in conjunction with SRP, enhances and facilitates the healing process in treated sites. The diode laser, preferred for its cost-effectiveness, portability, and user-friendly nature, simultaneously addresses the removal of diseased soft tissues, targets microorganisms, and induces an antibacterial effect within periodontal pockets.
Its favorable tissue penetration capabilities and absorption in pigmented tissues make it particularly adept at targeting pigmented bacteria and granulation tissue.
The emergence of low-abrasive and resorbable powders, used with subgingival delivery tools, sparks renewed interest in air-polishing devices (APDs) for periodontal treatment. Research indicates that APDs contribute to a reduction in post-operative patient discomfort and sensitivity, enhance patient acceptance, and result in minimal alterations to surrounding soft and hard tissues. Air-flow therapy may be particularly beneficial for challenging cases such as teeth with furcation involvement and sites with restricted access, traditionally posing difficulties for thorough debridement using conventional instrumentation.
Initially designed to eliminate biofilm and stains, APDs using abrasive powders were found detrimental to exposed root surfaces, gingiva, and certain restorative materials. Subsequently, there was a shift towards the adoption of resorbable powders with low abrasiveness, including glycine and erythritol, to mitigate adverse effects.
The recently introduced erythritol powder, a water-soluble, non-toxic sugar alcohol, and artificial sweetener, is extensively employed in the food industry. Erythritol powder air-polishing (EPAP) used as a monotherapy exhibits outcomes in supportive periodontal therapy comparable to those achieved through conventional power-driven and manual debridement.
There is a suggestion that erythritol powder may possess a prolonged antimicrobial effect on the subgingival biofilm, with studies indicating its capability to decrease the numbers of P. gingivalis and Aggregatibacter actinomycetemcomitans during supportive periodontal treatment.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mansoura, Egypt
- Mansoura Univeristy
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Systemically healthy patients. Patient with stageІ& stage ІІ periodontitis according to Classification of periodontal and peri-implant diseases and conditions 2017
Exclusion Criteria:
- Patients with any systemic disease linked to delayed wound healing, such as uncontrolled diabetes, autoimmune diseases, heart conditions, etc.
Current smokers. Patients underwent prior periodontal therapy within the last 6 months. Individuals who had used antibiotics in the previous 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: control group
Eight patients to be treated with only Scaling and root planning .
|
diode laser and erythritol used as adjunctive method in the treatment of periodontitis in addition to scaling and root planning
|
|
Experimental: erythritol group
Eight patients to be treated with erythritol air polishing as an adjunct to Scaling and root planning .
|
diode laser and erythritol used as adjunctive method in the treatment of periodontitis in addition to scaling and root planning
|
|
Experimental: laser group
Eight patients to be treated with dioad laser as an adjunct to Scaling and root planning .
|
diode laser and erythritol used as adjunctive method in the treatment of periodontitis in addition to scaling and root planning
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
probing depth and clinical attachment loss
Time Frame: baseline and 6 weeks follow up
|
decreasing probing depth and clinical attachment loss refer to healing of periodontal pocket
|
baseline and 6 weeks follow up
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: samah H elmeadawy, ph.D, Mansoura U
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- treatment of periodontitis
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
NCT07293962RecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage III
-
NCT07505251Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
NCT07590089CompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage III
-
NCT07599657RecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage III
-
NCT07517991CompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II
-
NCT06675578Not yet recruitingStage IV Periodontitis | Advanced Periodontitis | Stage III Periodontitis
-
NCT02423304UnknownGeneralized Adult Periodontitis
-
NCT07351682Not yet recruiting
-
NCT07387809Active, not recruiting
-
NCT07249450Completed
Clinical Trials on ultrasonic tips and Gracey curettes, airflow with erythritol and diode laser
-
NCT05112471CompletedPeriodontitis | Periodontal Diseases | Periodontitis, Aggressive
-
NCT04264624CompletedPeriodontitis, Aggressive | Periodontitis, Adult
-
NCT06358937Recruiting
-
NCT06109701RecruitingPeri-Implantitis | Peri-implant Mucositis
-
NCT06490679RecruitingPeriodontitis | Gingival Diseases | Periodontal Pocket | Gingival Bleeding
-
NCT06351982RecruitingPeriodontitis | Gingival Diseases | Periodontal Pocket | Gingival Bleeding
-
NCT06288919Active, not recruitingPeri-Implantitis | Peri-implant Mucositis | Dental Implant Failed
-
NCT02531555Completed